focus -WSS

focus

author：comprehensive 2025-10-01 14:59:45 - browse：312

A person stands in front of a Google office building -- coverage from STAT — NOAH SEELAM/AFP via Getty Images

Google’s generative AI system proved it can answer medical exam questions. But now the company is attempting a bigger leap — infusing its model with medical images such as X-rays and mammograms to help it communicate with doctors about data routinely used in patient care.

The effort, unveiled Wednesday, marks the beginning of a quest to make generative AI a more dynamic tool in medicine. While prior iterations of AI could either analyze images, or respond to questions, the company’s new model, known as Med-Palm 2, aims to put those capabilities together in a single system.

“Until this year, this was not on the table,” said Greg Corrado, a senior research scientist at Google. “Now you can build a system — and this is amazing to me, honestly, I did not expect this to happen now — but you can build a system where you give it an image, it writes a report, and then you can ask it follow-up questions.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

hotspot

WSS

Boston competes with Raleigh

Diagnostic tests are hitting their mathematical limits

ReNAgade cuts staff seven months after raising $300 million

Humana’s losses in Medicare Advantage tank its stock

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Boston competes with Raleigh

entertainment

focus

Wikipedia

Peter Hotez and the public health issue of online harassment

Takeda, Janssen join wearable maker to measure scratching

Psychedelics group wrestles with new pharma identity

30 years of 'Listening to Prozac'

Cancer drug shortages should be causing more outrage

Pancreatic cancer early detection could be helped by AI

Medicare proposal to cover medical devices draws a mixed reaction

Medicare drug price negotiation legal challenge met with skepticism

Cancer drug shortages should be causing more outrage

Vertex non

hotspot

Will the market for weight loss drugs really reach $100 billion?

Medicare Advantage insurers face 0.2% cut to 2025 payments

Merck, Johnson & Johnson CEOs will testify on high drug prices

What don’t we know about an Alzheimer’s drug side effect?

Biogen walks away from Aduhelm, years after polarizing approval

BIO selects John Crowley as new CEO

hotspot

hotspot

entertainment

hotspot